Argenica Therapeutics LtdASX: AGN

First Patient Dosed in Phase 2 Stroke Trial of ARG-007

Mar 28, 2024 at 1:45 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment